1. Rampoldi L, Danek A, Monaco AP. Clinical features and molecular bases of neuroacanthocytosis. Journal of molecular medicine (Berlin, Germany). 2002;80(8):475-91.
2. Ueno S, Maruki Y, Nakamura M, Tomemori Y, Kamae K, Tanabe H, et al. The gene encoding a newly discovered protein, chorein, is mutated in chorea-acanthocytosis. Nature genetics. 2001;28(2):121-2.
3. Walker RH, Jung HH, Dobson-Stone C, Rampoldi L, Sano A, Tison F, et al. Neurologic phenotypes associated with acanthocytosis. Neurology. 2007;68(2):92-8.
4. Gövert F, Schneider SA. Huntington's disease and Huntington's disease-like syndromes: an overview. Current opinion in neurology. 2013;26(4):420-7.
5. Jung HH, Danek A, Walker RH. Neuroacanthocytosis syndromes. Orphanet journal of rare diseases. 2011;6:68.
6. Katsube T, Shimono T, Ashikaga R, Hosono M, Kitagaki H, Murakami T. Demonstration of cerebellar atrophy in neuroacanthocytosis of 2 siblings. AJNR American journal of neuroradiology. 2009;30(2):386-8.
7. Dobson-Stone C, Velayos-Baeza A, Jansen A, Andermann F, Dubeau F, Robert F, et al. Identification of a VPS13A founder mutation in French Canadian families with chorea-acanthocytosis. Neurogenetics. 2005;6(3):151-8.
8. Walker RH, Schulz VP, Tikhonova IR, Mahajan MC, Mane S, Arroyo Muniz M, et al. Genetic diagnosis of neuroacanthocytosis disorders using exome sequencing. Movement disorders : official journal of the Movement Disorder Society. 2012;27(4):539-43.
9. Danek A, Walker RH. Neuroacanthocytosis. Current opinion in neurology. 2005;18(4):386-92.
10. Velayos-Baeza A, Vettori A, Copley RR, Dobson-Stone C, Monaco AP. Analysis of the human VPS13 gene family. Genomics. 2004;84(3):536-49.
11. Rampoldi L, Dobson-Stone C, Rubio JP, Danek A, Chalmers RM, Wood NW, et al. A conserved sorting-associated protein is mutant in chorea-acanthocytosis. Nature genetics. 2001;28(2):119-20.
12. Dobson-Stone C, Danek A, Rampoldi L, Hardie RJ, Chalmers RM, Wood NW, et al. Mutational spectrum of the CHAC gene in patients with chorea-acanthocytosis. European journal of human genetics : EJHG. 2002;10(11):773-81.
13. Dobson-Stone C, Velayos-Baeza A, Filippone LA, Westbury S, Storch A, Erdmann T, et al. Chorein detection for the diagnosis of chorea-acanthocytosis. Annals of neurology. 2004;56(2):299-302.
14. Kurano Y, Nakamura M, Ichiba M, Matsuda M, Mizuno E, Kato M, et al. In vivo distribution and localization of chorein. Biochemical and biophysical research communications. 2007;353(2):431-5.
15. Walker RH. Untangling the Thorns: Advances in the Neuroacanthocytosis Syndromes. Journal of movement disorders. 2015;8(2):41-54.
16. Föller M, Hermann A, Gu S, Alesutan I, Qadri SM, Borst O, et al. Chorein-sensitive polymerization of cortical actin and suicidal cell death in chorea-acanthocytosis. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 2012;26(4):1526-34.
17. Park JS, Neiman AM. VPS13 regulates membrane morphogenesis during sporulation in Saccharomyces cerevisiae. J Cell Sci. 2012;125(Pt 12):3004-11.
18. Park JS, Halegoua S, Kishida S, Neiman AM. A conserved function in phosphatidylinositol metabolism for mammalian Vps13 family proteins. PloS one. 2015;10(4):e0124836.
19. Kervestin S, Jacobson A. NMD: a multifaceted response to premature translational termination. Nat Rev Mol Cell Biol. 2012;13(11):700-12.
20. Walker RH, Liu Q, Ichiba M, Muroya S, Nakamura M, Sano A, et al. Self-mutilation in chorea-acanthocytosis: Manifestation of movement disorder or psychopathology? Movement disorders : official journal of the Movement Disorder Society. 2006;21(12):2268-9.
21. Liu J, Bader B, Danek A. Neuroacanthocytosis in china: a review of published reports. Tremor Other Hyperkinet Mov (N Y). 2014;4:248.
22. Benninger F, Afawi Z, Korczyn AD, Oliver KL, Pendziwiat M, Nakamura M, et al. Seizures as presenting and prominent symptom in chorea-acanthocytosis with c.2343del VPS13A gene mutation. Epilepsia. 2016;57(4):549-56.
23. Connolly BS, Hazrati LN, Lang AE. Neuropathological findings in chorea-acanthocytosis: new insights into mechanisms underlying parkinsonism and seizures. Acta neuropathologica. 2014;127(4):613-5.
24. Lossos A, Dobson-Stone C, Monaco AP, Soffer D, Rahamim E, Newman JP, et al. Early clinical heterogeneity in choreoacanthocytosis. Archives of neurology. 2005;62(4):611-4.
25. Klempír J, Roth J, Zárubová K, Písacka M, Spacková N, Tilley L. The McLeod syndrome without acanthocytes. Parkinsonism & related disorders. 2008;14(4):364-6.
26. Henkel K, Danek A, Grafman J, Butman J, Kassubek J. Head of the caudate nucleus is most vulnerable in chorea-acanthocytosis: a voxel-based morphometry study. Movement disorders : official journal of the Movement Disorder Society. 2006;21(10):1728-31.
27. Miki Y, Nishie M, Ichiba M, Nakamura M, Mori F, Ogawa M, et al. Chorea-acanthocytosis with upper motor neuron degeneration and 3419_3420 delCA and 3970_3973 delAGTC VPS13A mutations. Acta neuropathologica. 2010;119(2):271-3.
28. Kobal J, Dobson-Stone C, Danek A, Fidler V, Zvan B, Zaletel M. Chorea-acanthocytosis presenting as dystonia. Acta clinica Croatica. 2014;53(1):107-12.
29. Miquel M, Spampinato U, Latxague C, Aviles-Olmos I, Bader B, Bertram K, et al. Short and long term outcome of bilateral pallidal stimulation in chorea-acanthocytosis. PloS one. 2013;8(11):e79241.
30. Wang KL, Hess CW, Xu D, Zhang JG, Hu W, Meng FG. High Frequency Bilateral Globus Pallidus Interna Deep Brain Stimulation Can Improve Both Chorea and Dysarthria in Chorea-acanthocytosis. Parkinsonism & related disorders. 2019;62:248-50.
31. Al-Asmi A, Jansen AC, Badhwar A, Dubeau F, Tampieri D, Shustik C, et al. Familial temporal lobe epilepsy as a presenting feature of choreoacanthocytosis. Epilepsia. 2005;46(8):1256-63.
32. Dulski J, Sołtan W, Schinwelski M, Rudzińska M, Wójcik-Pędziwiatr M, Wictor L, et al. Clinical variability of neuroacanthocytosis syndromes-a series of six patients with long follow-up. Clinical neurology and neurosurgery. 2016;147:78-83.